Willkie Farr & Gallagher LLP is acting as legal advisor to Sanofi-Aventis and BNP Paribas is acting as financial advisor to the shareholders of Oenobiol on the transaction.
Deal Type Acquisition Sub-Category Majority Acquisition Deal Status Announced: 2009-10-30
Deal Participants
Target (Company) Laboratoire Oenobiol Acquirer (Company) Sanofi-Aventis S.A. Vendor (Company) Undisclosed Vendors
Deal Rationale
This acquisition will allow Sanofi-Aventis to reinforce its presence in the French market.

More News:
Market Updates |
Stock Alerts |
All Trading News |
Stock Index